Status:
COMPLETED
Grounding Effect on Alzheimer's Disease
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Alzheimer Disease
Insomnia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The investigators explore the effectiveness of grounding as a non-pharmacological therapy for treating sleep disturbances, anxiety, and depression in patients with mild AD.
Detailed Description
Grounding refers to having direct contact with the Earth, such as walking barefoot or lying on the ground. Research has found that grounding can improve inflammation, free radical damage, blood pressu...
Eligibility Criteria
Inclusion
- diagnosed with dementia, and CDR ≥ 0.5
- aged \> 50 years,
- sit with bilateral bare feet on the grounding mat
- able to answer the questionnaire
- able to sign the informed consent adequately.
Exclusion
- aged less than 50 years
- inability to sit with bilateral bare feet on the grounding mat
- currently taking anti-oxidative health supplements or anti-inflammatory medicine.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05246332
Start Date
August 1 2019
End Date
July 31 2020
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 833